After assessment of the patient, we explained the various neuroablative procedures, like Radiofrequency Ablation, for managing
cancer pain.
Daiichi Sankyo Company, Limited, a Japan-based pharmaceutical company announced yesterday that its Japan domestic group company, Daiichi Sankyo Propharma Co Ltd has received approval for the manufacture and sales in Japan of Narurapid (R) Tablets 1 mg, 2 mg, 4 mg (immediate release formulation) and Narusus (R) Tablets 2 mg, 6 mg, 12 mg, 24 mg (once daily extended release formulation) for
cancer pain treatments (generic name: hydromorphone hydrochloride).
Our data supports the hypothesis of potential under-treatment of
cancer pain and suggests that many more patients with advanced cancer and pain may benefit from a strong opioid analgesic," Dr.
Additionally, the report provides an overview of key players involved in therapeutic development for
Cancer Pain and features dormant and discontinued projects.
The report reviews key players involved in the therapeutics development for
Cancer Pain and enlists all their major and minor projects
Despite advances in understanding the aetiology of
cancer pain, pharmacological developments, pain assessment tools and management guidelines, pain often remains poorly managed.
Sometimes the
cancer pain is due to the medical interventions for diagnosis and treatment of disease or tumor itself.
Keywords:
Cancer pain, Therapeutic massage,
Cancer pain and complementary therapy, Effectiveness of massage in
cancer pain.
The international survey showed that more than half of the world's population live in countries where regulations aiming to stem drug misuse leave patients without access to opioid medicines for managing
cancer pain.
Ironically, the oncology community has struggled for years against the erroneous belief among patients and family members that effectively managing
cancer pain will make addicts of patients once they're cured.
Medication can help manage symptoms of nausea and shortness of breath while other drugs can control the vast majority of
cancer pain.
NORDIC BUSINESS REPORT-June 15, 2011--Orexo partner introduces
cancer pain drug in Canada(C)2011 M2 COMMUNICATIONS http://www.
